296 related articles for article (PubMed ID: 17987337)
1. Atypical ductal hyperplasia at margin of breast biopsy--is re-excision indicated?
Arora S; Menes TS; Moung C; Nagi C; Bleiweiss I; Jaffer S
Ann Surg Oncol; 2008 Mar; 15(3):843-7. PubMed ID: 17987337
[TBL] [Abstract][Full Text] [Related]
2. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting successful breast conservation for ductal carcinoma in situ.
Dillon MF; Mc Dermott EW; O'Doherty A; Quinn CM; Hill AD; O'Higgins N
Ann Surg Oncol; 2007 May; 14(5):1618-28. PubMed ID: 17443388
[TBL] [Abstract][Full Text] [Related]
4. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis.
Vicini FA; Kestin LL; Goldstein NS
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):722-30. PubMed ID: 15465188
[TBL] [Abstract][Full Text] [Related]
5. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision.
Wagoner MJ; Laronga C; Acs G
Am J Clin Pathol; 2009 Jan; 131(1):112-21. PubMed ID: 19095574
[TBL] [Abstract][Full Text] [Related]
6. Multicenter evaluation of the breast lesion excision system, a percutaneous, vacuum-assisted, intact-specimen breast biopsy device.
Sie A; Bryan DC; Gaines V; Killebrew LK; Kim CH; Morrison CC; Poller WR; Romilly AP; Schilling K; Sung JH
Cancer; 2006 Sep; 107(5):945-9. PubMed ID: 16874817
[TBL] [Abstract][Full Text] [Related]
7. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
8. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
Renshaw AA; Derhagopian RP; Martinez P; Gould EW
Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
[TBL] [Abstract][Full Text] [Related]
9. Predicting cancer on excision of atypical ductal hyperplasia.
Doren E; Hulvat M; Norton J; Rajan P; Sarker S; Aranha G; Yao K
Am J Surg; 2008 Mar; 195(3):358-61; discussion 361-2. PubMed ID: 18206849
[TBL] [Abstract][Full Text] [Related]
10. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer.
Smitt MC; Horst K
Ann Surg Oncol; 2007 Mar; 14(3):1040-4. PubMed ID: 17203329
[TBL] [Abstract][Full Text] [Related]
11. Lobular neoplasia on core-needle biopsy--clinical significance.
Arpino G; Allred DC; Mohsin SK; Weiss HL; Conrow D; Elledge RM
Cancer; 2004 Jul; 101(2):242-50. PubMed ID: 15241819
[TBL] [Abstract][Full Text] [Related]
12. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?
Valdes EK; Boolbol SK; Cohen JM; Feldman SM
Ann Surg Oncol; 2007 Mar; 14(3):1045-50. PubMed ID: 17206481
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy.
Deshaies I; Provencher L; Jacob S; Côté G; Robert J; Desbiens C; Poirier B; Hogue JC; Vachon E; Diorio C
Breast; 2011 Feb; 20(1):50-5. PubMed ID: 20619647
[TBL] [Abstract][Full Text] [Related]
14. Margin index is not a reliable tool for predicting residual disease after breast-conserving surgery for DCIS.
Fisher CS; Klimberg VS; Khan S; Gao F; Margenthaler JA
Ann Surg Oncol; 2011 Oct; 18(11):3155-9. PubMed ID: 21947593
[TBL] [Abstract][Full Text] [Related]
15. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.
Cabioglu N; Hunt KK; Sahin AA; Kuerer HM; Babiera GV; Singletary SE; Whitman GJ; Ross MI; Ames FC; Feig BW; Buchholz TA; Meric-Bernstam F
Ann Surg Oncol; 2007 Apr; 14(4):1458-71. PubMed ID: 17260108
[TBL] [Abstract][Full Text] [Related]
16. The significance of surgical margins for patients with atypical ductal hyperplasia.
Greene T; Tartter PI; Smith SR; Estabrook A
Am J Surg; 2006 Oct; 192(4):499-501. PubMed ID: 16978959
[TBL] [Abstract][Full Text] [Related]
17. Significance of flat epithelial atypia on mammotome core needle biopsy: Should it be excised?
Kunju LP; Kleer CG
Hum Pathol; 2007 Jan; 38(1):35-41. PubMed ID: 17095049
[TBL] [Abstract][Full Text] [Related]
18. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
[TBL] [Abstract][Full Text] [Related]
19. Relationship between initial margin status for invasive breast cancer and residual carcinoma after re-excision.
Kotwall C; Ranson M; Stiles A; Hamann MS
Am Surg; 2007 Apr; 73(4):337-43. PubMed ID: 17439024
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the diagnostic accuracy of a vacuum-assisted percutaneous intact specimen sampling device to a vacuum-assisted core needle sampling device for breast biopsy: initial experience.
Killebrew LK; Oneson RH
Breast J; 2006; 12(4):302-8. PubMed ID: 16848839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
